Enhabit, Inc.: A Sell Rating Amid Overly Optimistic Growth Expectations and Financial Challenges
TipRanksMar 13 01:56 ET
Enhabit Analyst Ratings
BenzingaMar 11 10:12 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD) and Enhabit, Inc (EHAB)
TipRanksMar 11 01:20 ET
UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating
MT NewswiresMar 8 11:35 ET
Enhabit, Inc (EHAB) Receives a Rating Update From a Top Analyst
TipRanksMar 7 07:38 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Enhabit, Inc (EHAB) and UnitedHealth (UNH)
TipRanksMar 7 05:12 ET
Enhabit Analyst Ratings
BenzingaMar 7 04:52 ET
Enhabit Analyst Ratings
BenzingaMar 6 09:20 ET
Jefferies Maintains Buy on Enhabit, Lowers Price Target to $14
BenzingaMar 6 09:21 ET
TD Cowen Remains a Hold on Enhabit, Inc (EHAB)
TipRanksMar 6 07:36 ET
TD Cowen Initiates Coverage On Enhabit With Market Perform Rating, Announces Price Target of $12
BenzingaDec 12, 2023 08:38 ET
Enhabit Analyst Ratings
BenzingaDec 12, 2023 08:36 ET
Analysts Conflicted on These NA Names: Enhabit, Inc (EHAB) and Forestar Group (FOR)
TipRanksNov 10, 2023 06:21 ET
Weak Performance and High Leverage: Maintaining Sell Rating for Enhabit, Inc
TipRanksOct 3, 2023 08:25 ET
Analysts Conflicted on These NA Names: Enhabit, Inc (EHAB) and Fortrea Holdings Inc. (FTRE)
TipRanksAug 15, 2023 06:40 ET
Goldman Sachs Sticks to Its Hold Rating for Enhabit, Inc (EHAB)
TipRanksAug 14, 2023 08:05 ET
Credit Suisse Maintains Neutral on Enhabit, Lowers Price Target to $12
BenzingaAug 11, 2023 09:04 ET
Enhabit Analyst Ratings
BenzingaAug 11, 2023 09:03 ET
Bank of America Securities Remains a Sell on Enhabit, Inc (EHAB)
TipRanksAug 11, 2023 05:05 ET
Enhabit, Inc (EHAB) Gets a Hold From Credit Suisse
TipRanksAug 10, 2023 06:35 ET
No Data
No Data